Stephanie Hoang
Genetic Counsellor / Assistant Clinical Professor
Department of Medical Genetics
8-25D Medical Sciences Building
Stephanie.Hoang@albertaprecisionlabs.ca
Stephanie Hoang is a genetic counsellor with Alberta Precision Laboratories. She completed a Bachelors of Science Degree with Honors in Molecular Biology and Genetics at the University of Alberta in 2008 and a Master of Science in Genetic Counselling at the University of British Columbia in 2010. She previously worked in ocular genetics for eight years. She currently works as a laboratory genetic counsellor with a focus on molecular genetics, cytogenetics, biochemical genetics, prenatal screening and newborn screening.
Ms. Hoang’s current research interests include cost utilization of genetic testing and communication of newborn screen results and laboratory testing.
AWARDS
2020 CAGC Research Grant Award
The identification of glucose-6-phosphate dehydrogenase deficiency by newborn screening: assessing the impact on families
Secondary Reporting of G6PD Deficiency on Newborn Screening.
Hoang SC, Blumenschein P, Lilley M, Olshaski L, Bruce A, Wright NAM, Ridsdale R, Christian S.
Int J Neonatal Screen. 2023 Mar 27;9(2):18.
Sickle cell trait newborn screen results: disclosure and management.
Lilley M, Hoang S, Blumenschein P, Peturson AM, Sosova I, Macneil L, Ridsdale R, Christian S. J Community Genet. 2021 Jan;12(1):137-142.
The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing.
Zhou JR, Ridsdale R, MacNeil L, Lilley M, Hoang S, Christian S, Blumenschein P, Wolan V, Bruce A, Singh G, Wright N, Parboosingh JS, Lamont RE, Sosova I.
Int J Neonatal Screen. 2021 Nov 16;7(4):78.
Two-year results after AAV2-mediated gene therapy for choroideremia: the Alberta experience.
Dimopoulos IS, Hoang SC, Radziwon A, Binczyk NM, Seabra MC, MacLaren RE, Somani R, Tennant MTS and MacDonald IM. Am J Ophthalmol. 2018 Jun 27;193:130-142.
Pathogenic mechanisms and the prospect of gene therapy for choroideremia.
Dimopoulos IS, Chan S, MacLaren RE, MacDonald IM. Expert Opin Orphan Drugs. 2015 Jul 1;3(7):787-798.